IFP Advisors’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50.7K Buy
3,897
+553
+17% +$6.29K ﹤0.01% 2390
2026
Q1
$38K Buy
3,344
+2,018
+152% +$21.9K ﹤0.01% 2398
2025
Q4
$17K Sell
1,326
-269
-17% -$3.32K ﹤0.01% 2801
2025
Q3
$17.8K Buy
+1,595
New +$15.4K ﹤0.01% 2637
2025
Q2
Sell
-10
Closed -$98 4309
2025
Q1
$94 Hold
10
﹤0.01% 3866
2024
Q4
$92 Buy
+10
New +$74 ﹤0.01% 4060
2020
Q3
Sell
-312
Closed -$2.96K 2841
2020
Q2
$3K Sell
312
-40
-11% -$412 ﹤0.01% 2237
2020
Q1
$4K Sell
352
-63
-15% -$791 ﹤0.01% 2118
2019
Q4
$7K Sell
415
-34
-8% -$519 ﹤0.01% 2056
2019
Q3
$9K Buy
+449
New +$8.78K ﹤0.01% 2116
2019
Q1
Sell
-292
Closed -$6K 2392
2018
Q4
$6K Sell
292
-836
-74% -$17.3K ﹤0.01% 2738
2018
Q3
$25K Buy
1,128
+590
+110% +$13.1K ﹤0.01% 2331
2018
Q2
$12K Buy
538
+400
+290% +$8.18K ﹤0.01% 2774
2018
Q1
$2K Hold
138
﹤0.01% 3474
2017
Q4
$2K Hold
138
﹤0.01% 3525
2017
Q3
$2K Buy
+138
New +$2.32K ﹤0.01% 3715

Other funds holding ANGO

IFP Advisors's ANGO Position: Q2 2026 in Review

IFP Advisors increased its AngioDynamics (ANGO) stake by 17% in Q2 2026, buying an estimated $6.29K and bringing the position to 3,897 shares worth $50.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2390.

IFP Advisors first reported a position in ANGO in Q3 2017 and has held it in 16 quarters since. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • IFP Advisors held 3,897 shares of AngioDynamics worth $50.7K as of Q2 2026.
  • IFP Advisors bought 553 AngioDynamics shares in Q2 2026, an estimated $6.29K.
  • AngioDynamics made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #2390 holding.
  • IFP Advisors first reported a position in AngioDynamics in Q3 2017 and has held it in 16 quarters since.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.